Abstract
Acute ischemic stroke continues to be one of the leading causes of disability and death and is a financial burden to an already taxed health care system. Much research and investigation has been carried out over the past decade on various recanalization devices aimed at restoring cerebral blood flow. Despite the rapidly improving technical abilities of these devices, it has been difficult to demonstrate corresponding improved clinical outcomes. This article will describe the application of the most recent generation of these devices and briefly discuss the ongoing discrepancy between these technical achievements and stroke outcomes.
Original language | English (US) |
---|---|
Pages (from-to) | 105-110 |
Number of pages | 6 |
Journal | Methodist DeBakey cardiovascular journal |
Volume | 10 |
Issue number | 2 |
State | Published - Apr 1 2014 |
Keywords
- Brain Ischemia
- Cerebrovascular Circulation
- Endovascular Procedures
- Fibrinolytic Agents
- Humans
- Infusions, Intra-Arterial
- Infusions, Intravenous
- Risk Factors
- Stroke
- Thrombectomy
- Thrombolytic Therapy
- Treatment Outcome
ASJC Scopus subject areas
- General Medicine